Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing Exacerbations

CompletedOBSERVATIONAL

Enrollment

3,333

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

September 30, 2010

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

TIO

Patients receiving tiotropium bromide at index within the study period.

DRUG

TIO+FSC

Patients receiving tiotropium bromide plus fluticasone propionate-salmeterol xinafoate combination at time of index within the study period.